[96a5a0]: / output / allTrials / identified / NCT00321620_identified.json

Download this file

271 lines (271 with data), 10.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
{
"info": {
"nct_id": "NCT00321620",
"official_title": "A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer",
"inclusion_criteria": "* Men >/= 18 years of age with histologically confirmed prostate cancer\n* Radiographic evidence of at least one bone metastasis\n* Failure of at least one hormonal therapy as evidenced by a rising PSA\n* Serum testosterone level of <50 ng/dL\n* ECOG PS 0, 1, or 2\n* Adequate organ function\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Current or prior IV bisphosphonate administration\n* Current or prior oral bisphosphonates for bone mets\n* Life expectancy of less than 6 months",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Men >/= 18 years of age with histologically confirmed prostate cancer",
"criterions": [
{
"exact_snippets": "Men",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
},
{
"exact_snippets": "18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "histologically confirmed prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "confirmation_method",
"expected_value": "histologically confirmed"
}
]
}
]
},
{
"line": "* Radiographic evidence of at least one bone metastasis",
"criterions": [
{
"exact_snippets": "Radiographic evidence of at least one bone metastasis",
"criterion": "bone metastasis",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "radiographic"
},
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "metastasis"
}
}
]
}
]
},
{
"line": "* Failure of at least one hormonal therapy as evidenced by a rising PSA",
"criterions": [
{
"exact_snippets": "Failure of at least one hormonal therapy",
"criterion": "hormonal therapy",
"requirements": [
{
"requirement_type": "failure",
"expected_value": true
}
]
},
{
"exact_snippets": "rising PSA",
"criterion": "PSA",
"requirements": [
{
"requirement_type": "trend",
"expected_value": "rising"
}
]
}
]
},
{
"line": "* Serum testosterone level of <50 ng/dL",
"criterions": [
{
"exact_snippets": "Serum testosterone level of <50 ng/dL",
"criterion": "serum testosterone level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "ng/dL"
}
}
]
}
]
},
{
"line": "* ECOG PS 0, 1, or 2",
"criterions": [
{
"exact_snippets": "ECOG PS 0, 1, or 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
}
]
},
{
"line": "* Adequate organ function",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Current or prior IV bisphosphonate administration",
"criterions": [
{
"exact_snippets": "Current or prior IV bisphosphonate administration",
"criterion": "IV bisphosphonate administration",
"requirements": [
{
"requirement_type": "timing",
"expected_value": [
"current",
"prior"
]
}
]
}
]
},
{
"line": "* Current or prior oral bisphosphonates for bone mets",
"criterions": [
{
"exact_snippets": "Current or prior oral bisphosphonates",
"criterion": "oral bisphosphonates",
"requirements": [
{
"requirement_type": "usage",
"expected_value": [
"current",
"prior"
]
}
]
},
{
"exact_snippets": "bone mets",
"criterion": "bone metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Life expectancy of less than 6 months",
"criterions": [
{
"exact_snippets": "Life expectancy of less than 6 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}